- Global Pharma News & Resources

Blood Screening Market to achieve CAGR of 7.7% between 2023 and 2032, owing to increasing number of blood donation worldwide | insightSLICE

The global Blood Screening market size was estimated to be US$ 2.3 billion in 2021 and is expected grow at a CAGR of 7.7% between 2023 to 2032.

Blood Screening Market Report will provide insights into Global Share, Developments, Statistics, and Forecasts, for the year 2022-2032. This study also takes into account the competitive environment and will give an outline of the top market participants in the Blood Screening Market as well as their plans for the market.

Additionally, the report will also include statistics regarding important advancements, global and regional sales networks, business strategies, research and development initiatives, staff strength, and key executives for all significant market participants.

Access the sample report:

The Becton, Dickinson, and Company generated a net income of USD 17.3 billion for the year 2019, and their product and service results indicate that the BD Medical business segment accounted for the majority of the company’s revenue in said year.

The key players of the Global Blood Screening Market are:

Beckman Coulter (Danaher Corporation), Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Abbott Laboratories, Grifols, S.A., Siemens, Ortho Clinical Diagnostics, and Thermo Fisher Scientific.

Major reasons and factors for the growth of this market are covered in this report:

The main factors influencing the worldwide blood screening market include rising awareness of blood donation, rising demand for healthy blood for clinical applications, the incidence of infectious illnesses, an increase in surgical operations, and strict rules to check blood quality.

The development of clinical research has aided in the discovery of novel pathogens that cause infectious diseases, which is anticipated to support the expansion of the blood screening market in the years to come.

Since the government is providing incentives for donating blood, blood donor awareness is growing in middle-income and low-income nations. In turn, this has stimulated the introduction of blood screening procedures to assure the absence of disease markers and in turn, expanded the amount of blood supplied.

Even as the number of surgical procedures has increased, there is a greater need for quality blood to replenish the blood lost during surgical procedures. The need for effective blood screening techniques has increased as a result. As a result, the global market for blood screening is anticipated to expand significantly during the coming years.

Read more about the report inclusions:

Mentioning several factors with examples:

With a special focus on every company involved in the global Blood Screening Market, this report offers an in-depth analysis of leading companies with a majority share of the global market. This will help our clients to identify the key players that focus on Blood Screening Services.

Additionally, the market shares of well-known businesses operating in this market would be calculated to provide detailed statistics.

For example, from this report, Becton, Dickinson, and Company operate three divisions namely BD Medical, BD Life Sciences, and BD Interventional. The company’s BD Medical business contributed US$ 9.1 billion in 2019 and is the one which is involved in the Blood Screening Market.

The report on the Global Blood Screening Market will include data for all the major companies involved in this sector along with their business strategies, product portfolios, SWOT assessments, and the latest research and development ventures.

This report will also take into account the company segments that are engaged in the Blood Screening Market and their services. One of the sections is focussed on the research of the company’s product portfolio and will include all of the products and services delivered through such segments.

Similarly, to that, the recent advancements section of this report will focus on the most recent developments in the global Blood Screening Market for the years 2022 to 2032, including their growth plans, partnerships, and strategic product launches and partnerships.

Global Blood Screening Market Key Segments:

By Technology

  • Nucleic Acid Amplification Test (NAT)
  • Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
  • Next-Generation Sequencing (NGS)
  • Western Blotting

By Product

  • Reagent
  • Instrument

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Related reports:

Global Vaccine Storage Equipment Market:

Global Facial Rejuvenation Market:

Regional factors are also covered in the report for blood screening market:

North America held the greatest market share for blood screening globally for the year 2019, and it is anticipated that it will continue to expand significantly over the coming years.

The prevalence of infectious illnesses, the increasing need for healthy blood, and an increase in the volume of donated blood are the main drivers of the blood screening market in North America.

The market for blood screening in North America is anticipated to increase as a result of the presence of top product manufacturers and rising investments in product innovation. During the projected period, the market in Asia Pacific is anticipated to develop at the fastest rate.

The main drivers of the growth of the Asia Pacific blood screening market are the development of the healthcare infrastructure, increased awareness of blood donation, and the incidence of infectious illnesses.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 29-Nov-2022